CN Stock MarketDetailed Quotes
002317 Guangdong Zhongsheng Pharmaceutical
- 12.96
- -0.41-3.07%
Market Closed Dec 13 15:00 CST
11.04BMarket Cap83.08P/E (TTM)
13.33High12.93Low252.62KlotVolume13.32Open13.37Pre Close330.86MTurnover3.32%Turnover Ratio41.94P/E (Static)851.56MShares18.2252wk High2.52P/B9.87BFloat Cap10.0252wk Low14.71Limit Up761.62MShs Float40.90Historical High12.03Limit Down2.99%Amplitude2.52Historical Low0.20Dividend TTM13.10Avg Price163.72KlotAsk1.54%Div YieldTTM100Lot Size82.77KlotBid
Guangdong Zhongsheng Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -7.88%1.91B | -7.96%1.36B | -14.15%641.12M | -2.45%2.61B | 4.02%2.07B | 11.80%1.48B | 10.50%746.77M | 10.17%2.68B | 9.19%1.99B | 9.57%1.33B |
| Operating revenue | -7.88%1.91B | -7.96%1.36B | -14.15%641.12M | -2.45%2.61B | 4.02%2.07B | 11.80%1.48B | 10.50%746.77M | 10.17%2.68B | 9.19%1.99B | 9.57%1.33B |
| Other operating revenue | ---- | 91.34%8.42M | ---- | -3.10%10.39M | ---- | -47.90%4.4M | ---- | -15.85%10.72M | ---- | 71.74%8.44M |
| Interest income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Commission income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Premiums earned | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total operating cost | -2.46%1.7B | -4.53%1.17B | -6.23%564.7M | -2.32%2.3B | 2.95%1.74B | 10.83%1.23B | 13.73%602.24M | 11.80%2.35B | 12.95%1.69B | 13.46%1.11B |
| Operating cost | 2.13%837.94M | 3.50%587.7M | -3.01%278.95M | 14.93%1.08B | 21.63%820.46M | 26.37%567.85M | 28.77%287.61M | 16.61%940.49M | 11.96%674.52M | 15.89%449.35M |
| Operating tax surcharges | 3.68%17.1M | 14.82%13.59M | -2.75%6.93M | 3.27%24.92M | -2.55%16.49M | 6.00%11.84M | 11.36%7.13M | 0.33%24.14M | -8.91%16.92M | -21.65%11.16M |
| Operating expense | -7.31%645.88M | -12.87%442.51M | -10.96%213.63M | -11.02%889.9M | -5.31%696.81M | 6.03%507.87M | 7.46%239.92M | 6.31%1B | 6.62%735.9M | 2.32%478.98M |
| Administration expense | -3.23%108.47M | -8.59%69.54M | -13.71%32.99M | -9.27%155.65M | -5.24%112.09M | -1.89%76.08M | 4.92%38.23M | 17.76%171.54M | 19.60%118.3M | 19.69%77.54M |
| Financial expense | -64.92%6.19M | -70.05%4.02M | -23.41%2.23M | -70.67%16.78M | -70.81%17.64M | -61.40%13.44M | -78.78%2.91M | 18.35%57.23M | 1,892.07%60.45M | 1,911.20%34.81M |
| -Interest expense (Financial expense) | -34.14%23.24M | -31.04%16.12M | -13.59%8.52M | -36.05%46.91M | -43.03%35.29M | -41.95%23.38M | -51.38%9.86M | -0.62%73.36M | 175.99%61.96M | 177.26%40.28M |
| -Interest Income (Financial expense) | 15.21%-16.28M | -6.35%-12.88M | -4.37%-6.49M | -10.80%-30.61M | 1.96%-19.2M | 4.92%-12.11M | 0.38%-6.22M | -5.92%-27.63M | -2.13%-19.58M | -0.03%-12.73M |
| Research and development | 6.13%86.09M | 7.50%57.46M | 13.34%29.97M | -18.66%127.37M | -8.41%81.12M | -8.46%53.45M | 0.24%26.44M | 14.53%156.59M | 1.61%88.57M | 39.38%58.39M |
| Credit Impairment Loss | -79.20%-6.94M | -11.81%-5.45M | 83.66%-532.78K | 110.73%398.94K | 21.59%-3.87M | -12.35%-4.87M | 8.27%-3.26M | -125.59%-3.72M | -130.47%-4.94M | -34.91%-4.34M |
| Asset Impairment Loss | ---919.36K | ---919.36K | ---1.51M | -1,445.75%-16.75M | --0 | --0 | --0 | 84.93%-1.08M | --0 | --0 |
| Other net revenue | 378.10%29.98M | -86.82%-31.97M | -200.56%-17.15M | -133.88%-16.32M | -102.64%-10.78M | -170.22%-17.11M | 128.90%17.06M | 436.15%48.17M | -114.47%-5.32M | -76.10%24.37M |
| Fair value change income | 110.70%5.86M | 4.74%-47.82M | -8,460.04%-25.5M | -234.41%-65.23M | -106.29%-54.77M | -436.80%-50.2M | 100.50%304.99K | 70.77%-19.51M | -631.06%-26.55M | -83.37%14.9M |
| Invest income | 19.71%20.84M | 20.69%15.26M | -7.01%7.17M | -49.24%23.53M | -1.90%17.41M | 16.61%12.64M | 58.31%7.71M | 124.24%46.36M | -1.20%17.75M | 11.34%10.84M |
| Net open hedge income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Including: Investment income associates | 1,005.80%3.34M | 196.53%2.38M | -45.55%739.02K | 38.11%-228.48K | 1,734.78%301.65K | 658.79%802.65K | 575.13%1.36M | 55.68%-369.16K | 110.04%16.44K | 111.08%105.78K |
| Exchange income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Asset deal income | -99.87%28.18K | -99.87%28.18K | --0 | 47.59%21.68M | 85,814.49%21.68M | 200,009.99%21.68M | --11.04M | 2,421.17%14.69M | 32.30%25.24K | -156.84%-10.84K |
| Other revenue | 26.72%11.11M | 90.47%6.93M | 154.78%3.22M | 75.33%20.04M | 4.42%8.76M | 22.52%3.64M | 70.83%1.26M | -54.32%11.43M | 28.14%8.39M | -47.06%2.97M |
| Operating profit | -25.18%236.33M | -32.85%157.57M | -63.32%59.27M | -20.18%298.73M | 8.47%315.88M | -2.23%234.66M | 85.26%161.58M | 19.70%374.26M | -19.11%291.23M | -28.05%240M |
| Add:Non operating Income | -63.15%89.5K | -50.47%62.51K | -25.88%13.58K | 393.22%1.19M | 31.72%242.91K | -21.65%126.21K | -70.24%18.32K | -86.11%241.84K | -82.27%184.41K | -83.09%161.08K |
| Less:Non operating expense | 3,220.61%58.7M | 3,947.91%58.02M | 156.28%170.84K | 162.27%16.27M | -68.38%1.77M | -42.99%1.43M | -83.23%66.66K | 25.97%6.2M | 178.86%5.59M | 38.14%2.51M |
| Total profit | -43.47%177.72M | -57.31%99.61M | -63.40%59.12M | -22.98%283.66M | 9.99%314.36M | -1.81%233.35M | 85.92%161.54M | 19.01%368.3M | -20.40%285.82M | -28.56%237.65M |
| Less:Income tax cost | 18.97%41.81M | -1.56%20.77M | -55.70%10.41M | -36.25%33.76M | -11.02%35.15M | -43.20%21.1M | 76.96%23.49M | 52.13%52.95M | -23.84%39.5M | -24.16%37.15M |
| Net profit | -51.32%135.91M | -62.86%78.83M | -64.71%48.71M | -20.75%249.9M | 13.35%279.21M | 5.86%212.25M | 87.54%138.05M | 14.81%315.35M | -19.82%246.32M | -29.33%200.49M |
| Net profit from continuing operation | -51.32%135.91M | -62.86%78.83M | -64.71%48.71M | -20.75%249.9M | 13.35%279.21M | 5.86%212.25M | 87.54%138.05M | 14.81%315.35M | -19.82%246.32M | -29.33%200.49M |
| Net income from discontinuing operating | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Less:Minority Profit | -4,492.04%-12.89M | -331.87%-8.58M | -94.33%-2.58M | -99.53%-13.37M | 88.34%-280.74K | 312.39%3.7M | -35.69%-1.33M | -126.34%-6.7M | 63.33%-2.41M | 57.64%-1.74M |
| Net profit of parent company owners | -46.76%148.8M | -58.09%87.41M | -63.20%51.29M | -18.25%263.27M | 12.37%279.5M | 3.12%208.55M | 86.86%139.38M | 16.00%322.05M | -20.73%248.73M | -29.73%202.24M |
| Earning per share | ||||||||||
| Basic earning per share | -47.06%0.18 | -61.54%0.1 | -64.71%0.06 | -20.00%0.32 | 9.68%0.34 | 4.00%0.26 | 88.89%0.17 | 14.29%0.4 | -20.51%0.31 | -30.56%0.25 |
| Diluted earning per share | -47.06%0.18 | -61.54%0.1 | -64.71%0.06 | -20.00%0.32 | 9.68%0.34 | 4.00%0.26 | 88.89%0.17 | 14.29%0.4 | -20.51%0.31 | -30.56%0.25 |
| Other composite income | -111.99%-448.47K | -110.96%-145.67K | -30.10%605.09K | -57.95%2.91M | -41.82%3.74M | -77.75%1.33M | -83.38%865.6K | -76.50%6.93M | -75.73%6.43M | -56.72%5.97M |
| Other composite income of parent company owners | -111.99%-448.47K | -110.96%-145.67K | -30.10%605.09K | -57.95%2.91M | -41.82%3.74M | -77.75%1.33M | -83.38%865.6K | -76.50%6.93M | -75.73%6.43M | -56.72%5.97M |
| Other composite income of minority owners | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total composite income | -52.13%135.46M | -63.16%78.69M | -64.50%49.32M | -21.55%252.81M | 11.95%282.96M | 3.44%213.58M | 76.24%138.91M | 5.96%322.28M | -24.26%252.75M | -30.60%206.47M |
| Total composite income of parent company owners | -47.62%148.35M | -58.42%87.26M | -62.99%51.9M | -19.09%266.19M | 11.00%283.24M | 0.80%209.88M | 75.74%140.24M | 7.12%328.98M | -25.01%255.16M | -30.97%208.21M |
| Total composite income of minority owners | -4,492.04%-12.89M | -331.87%-8.58M | -94.33%-2.58M | -99.53%-13.37M | 88.34%-280.74K | 312.39%3.7M | -35.69%-1.33M | -126.34%-6.7M | 63.33%-2.41M | 57.64%-1.74M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Zhonghua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
